MetaADEDB 2.0 @ LMMD
Mercaptopurine
(GLVAUDGFNGKCSF-UHFFFAOYSA-N)
Structure
SMILES
S=c1nc[nH]c2c1[nH]cn2
Type(s)
Approved
ATC code(s)
L01BB02
Molecular Formula:
C5H4N4S
Molecular Weight:
152.177
Log P:
1.0155
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
2
TPSA:
89.45
CAS Number(s):
50-44-2; 157930-13-7; 157930-14-8
Synonym(s)
1.
Mercaptopurine
2.
6-Mercaptopurine
3.
1,7-Dihydro-6H-purine-6-thione
4.
6-Mercaptopurine Monohydrate
5.
6-Thiohypoxanthine
6.
6-Thiopurine
7.
6H-Purine-6-thione, 1,7-dihydro-
8.
BW 57-323H
9.
Leupurin
10.
Mecaptopurine Anhydrous
11.
Mercaptopurina Wellcome
12.
Puri-Nethol
13.
Purimethol
14.
Purinethol
15.
6 Mercaptopurine
16.
6 Mercaptopurine Monohydrate
17.
6 Thiohypoxanthine
18.
6 Thiopurine
19.
BW 57 323H
20.
BW 57323H
External Link(s)
MeSHD015122
PubChem Compound667490
BindingDB50423778
ChEBI50667
2208
94796
CHEMBLCHEMBL1425
DrugBankDB01033
DrugCentral1708
IUPHAR/BPS Guide to PHARMACOLOGY7226
KEGGcpd:C01756
cpd:C02380
dr:D04931
Therapeutic Target DatabaseD09UZO
ZINC4658290
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Febrile NeutropeniaFAERS: 27OFFSIDES
US FAERS
2PancreatitisFAERS: 23
Canada Vigilance: 8		25217962CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
3NauseaFAERS: 21
Canada Vigilance: 1		18711101CTD
SIDER
Canada Vigilance
US FAERS
4VomitingFAERS: 21
Canada Vigilance: 1		Canada Vigilance
SIDER
US FAERS
5Diffuse Large B-Cell LymphomaFAERS: 18OFFSIDES
US FAERS
6NeutropeniaFAERS: 13US FAERS
7PancytopeniaFAERS: 13
Canada Vigilance: 1		4552812CTD
SIDER
Canada Vigilance
US FAERS
8Portal HypertensionFAERS: 13US FAERS
9Drug ineffectiveFAERS: 12
Canada Vigilance: 37		Canada Vigilance
OFFSIDES
US FAERS
10HeadacheFAERS: 11US FAERS
11Hepatosplenic T-cell lymphomaFAERS: 10
Canada Vigilance: 1		Canada Vigilance
OFFSIDES
SIDER
US FAERS
12PainFAERS: 10
Canada Vigilance: 2		Canada Vigilance
US FAERS
13LeukopeniaFAERS: 9
Canada Vigilance: 2

View details

4552812
8050312
25108385
28914446
 		CTD
SIDER
Canada Vigilance
US FAERS
14White blood cell count decreasedFAERS: 9US FAERS
15AlopeciaFAERS: 8SIDER
US FAERS
16HepatotoxicityFAERS: 8
Canada Vigilance: 2		Canada Vigilance
OFFSIDES
SIDER
US FAERS
17ChillsFAERS: 7US FAERS
18FatigueFAERS: 718711101CTD
OFFSIDES
US FAERS
19OverdoseFAERS: 7US FAERS
20Toxicity to various agentsFAERS: 7US FAERS
21Drug dispensing errorFAERS: 6OFFSIDES
US FAERS
22Histiocytosis haematophagicFAERS: 6OFFSIDES
US FAERS
23ThrombocytopeniaFAERS: 64552812
8050312		CTD
SIDER
US FAERS
24Abdominal PainFAERS: 5OFFSIDES
US FAERS
25AstheniaFAERS: 5US FAERS
26DehydrationFAERS: 5US FAERS
27Weight decreasedFAERS: 5
Canada Vigilance: 1		Canada Vigilance
US FAERS
28Accidental overdoseFAERS: 4US FAERS
29ArthralgiaFAERS: 4
Canada Vigilance: 2		Canada Vigilance
SIDER
US FAERS
30CholestasisFAERS: 4SIDER
US FAERS
31Drug dose omissionFAERS: 4OFFSIDES
US FAERS
32Drug level increasedFAERS: 4US FAERS
33Lipase increasedFAERS: 4
Canada Vigilance: 1		Canada Vigilance
US FAERS
34MYELODYSPLASTIC SYNDROMEFAERS: 4
Canada Vigilance: 1		Canada Vigilance
US FAERS
35Night sweatsFAERS: 4
Canada Vigilance: 1		Canada Vigilance
US FAERS
36Nodular regenerative hyperplasiaFAERS: 4US FAERS
37SepsisFAERS: 4SIDER
US FAERS
38Squamous cell carcinomaFAERS: 4US FAERS
39TachycardiaFAERS: 4US FAERS
40Transmission of drug via semenFAERS: 4OFFSIDES
US FAERS
41jaundiceFAERS: 4
Canada Vigilance: 1		Canada Vigilance
US FAERS
42Accidental exposureFAERS: 3OFFSIDES
US FAERS
43Alanine Aminotransferase IncreasedFAERS: 3OFFSIDES
US FAERS
44Amylase increasedFAERS: 3
Canada Vigilance: 1		Canada Vigilance
US FAERS
45AnxietyFAERS: 3US FAERS
46Aspartate Aminotransferase IncreasedFAERS: 3
Canada Vigilance: 1		Canada Vigilance
US FAERS
47ChromaturiaFAERS: 3US FAERS
48Epstein-Barr virus test positiveFAERS: 3OFFSIDES
US FAERS
49Feeling abnormalFAERS: 3US FAERS
50Hepatic EncephalopathyFAERS: 3US FAERS
51HepatitisFAERS: 3
Canada Vigilance: 3		Canada Vigilance
US FAERS
52LymphopeniaFAERS: 3US FAERS
53MalaiseFAERS: 3
Canada Vigilance: 2		Canada Vigilance
US FAERS
54MyalgiaFAERS: 3US FAERS
55Neutrophil count decreasedFAERS: 3US FAERS
56Pharmaceutical product complaintFAERS: 3US FAERS
57Pregnancy of partnerFAERS: 3OFFSIDES
US FAERS
58PruritusFAERS: 3US FAERS
59Accidental exposure to productFAERS: 2US FAERS
60Activities of daily living impairedFAERS: 2US FAERS
61AneurysmFAERS: 2US FAERS
62Back PainFAERS: 2US FAERS
63Blood count abnormalFAERS: 2US FAERS
64Chest PainFAERS: 2US FAERS
65ColitisFAERS: 2US FAERS
66DizzinessFAERS: 2US FAERS
67Drug toxicityFAERS: 2US FAERS
68EnteritisFAERS: 2
Canada Vigilance: 1		Canada Vigilance
US FAERS
69Expired product administeredFAERS: 2US FAERS
70Extranodal marginal zone B-cell lymphoma (MALT type)FAERS: 2US FAERS
71FlatulenceFAERS: 2
Canada Vigilance: 1		Canada Vigilance
US FAERS
72Gastrointestinal ulcerFAERS: 2US FAERS
73HypophagiaFAERS: 2OFFSIDES
US FAERS
74ImmunosuppressionFAERS: 2OFFSIDES
US FAERS
75InfectionFAERS: 2OFFSIDES
US FAERS
76InfluenzaFAERS: 2US FAERS
77LeukocytosisFAERS: 2US FAERS
78LymphomaFAERS: 2OFFSIDES
US FAERS
79MeningoradiculitisFAERS: 2US FAERS
80Ocular icterusFAERS: 2OFFSIDES
US FAERS
81PhlebosclerosisFAERS: 2US FAERS
82PneumoniaFAERS: 2US FAERS
83Product quality issueFAERS: 2US FAERS
84Pulmonary FibrosisFAERS: 2US FAERS
85Pulmonary granulomaFAERS: 2US FAERS
86Rash erythematousFAERS: 2US FAERS
87Renal massFAERS: 2OFFSIDES
US FAERS
88Septic ShockFAERS: 2US FAERS
89SplenomegalyFAERS: 2
Canada Vigilance: 1		Canada Vigilance
US FAERS
90T-Cell LymphomaFAERS: 2OFFSIDES
US FAERS
91Transaminases increasedFAERS: 2US FAERS
92UlcerFAERS: 2
Canada Vigilance: 1		Canada Vigilance
OFFSIDES
SIDER
US FAERS
93Unevaluable eventFAERS: 2US FAERS
94Urinary tract infectionFAERS: 2
Canada Vigilance: 1		Canada Vigilance
US FAERS
95Abdominal discomfortFAERS: 1US FAERS
96AcneFAERS: 1US FAERS
97Alcohol interactionFAERS: 1US FAERS
98Aortic AneurysmFAERS: 1US FAERS
99AscitesFAERS: 1US FAERS
100Basal cell carcinomaFAERS: 1OFFSIDES
US FAERS
101Bilirubin conjugated increasedFAERS: 1OFFSIDES
US FAERS
102Blood alkaline phosphatase increasedFAERS: 1US FAERS
103Blood bilirubin unconjugated increasedFAERS: 1OFFSIDES
US FAERS
104Blood creatinine increasedFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
105Blood iron decreasedFAERS: 1US FAERS
106Blood lactate dehydrogenase increasedFAERS: 1US FAERS
107Blood sodium decreasedFAERS: 1US FAERS
108Blood urine presentFAERS: 1US FAERS
109Combined immunodeficiencyFAERS: 1US FAERS
110CraniosynostosisFAERS: 1US FAERS
111Diabetes MellitusFAERS: 1US FAERS
112Disease ProgressionFAERS: 1US FAERS
113Disease complicationFAERS: 1US FAERS
114Disease recurrenceFAERS: 1
Canada Vigilance: 1		Canada Vigilance
OFFSIDES
US FAERS
115Drug clearance decreasedFAERS: 1US FAERS
116Drug level decreasedFAERS: 1US FAERS
117Drug name confusionFAERS: 1US FAERS
118Drug resistanceFAERS: 1US FAERS
119DyspepsiaFAERS: 1US FAERS
120DysplasiaFAERS: 1US FAERS
121EczemaFAERS: 1OFFSIDES
US FAERS
122EmbolismFAERS: 1US FAERS
123Enteropathy-Associated T-Cell LymphomaFAERS: 1US FAERS
124Enzyme abnormalityFAERS: 1OFFSIDES
US FAERS
125EpistaxisFAERS: 1OFFSIDES
US FAERS
126Epstein-Barr virus antibody positiveFAERS: 1US FAERS
127Erythema NodosumFAERS: 117576940CTD
OFFSIDES
US FAERS
128Escherichia sepsisFAERS: 1OFFSIDES
US FAERS
129Exposure via body fluidFAERS: 1US FAERS
130Febrile bone marrow aplasiaFAERS: 1US FAERS
131GastritisFAERS: 1US FAERS
132GastroenteritisFAERS: 1US FAERS
133Gastrointestinal infectionFAERS: 1US FAERS
134HLA marker study positiveFAERS: 1US FAERS
135Hepatic necrosisFAERS: 1
Canada Vigilance: 1		Canada Vigilance
SIDER
US FAERS
136HypersensitivityFAERS: 1SIDER
US FAERS
137HyperthyroidismFAERS: 1US FAERS
138HypoxiaFAERS: 1US FAERS
139Impaired work abilityFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
140IncontinenceFAERS: 1US FAERS
141Incorrect dose administeredFAERS: 1OFFSIDES
US FAERS
142Increased tendency to bruiseFAERS: 1US FAERS
143Influenza B virus test positiveFAERS: 1US FAERS
144Intestinal ObstructionFAERS: 1
Canada Vigilance: 1		Canada Vigilance
OFFSIDES
US FAERS
145Intestinal resectionFAERS: 1OFFSIDES
US FAERS
146Iron deficiencyFAERS: 1US FAERS
147LymphadenopathyFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
148Lymphocyte count decreasedFAERS: 1
Canada Vigilance: 1		Canada Vigilance
OFFSIDES
US FAERS
149Maternal exposure during pregnancyFAERS: 1US FAERS
150Monocyte percentage increasedFAERS: 1US FAERS
151Mood swingsFAERS: 1US FAERS
152Musculoskeletal stiffnessFAERS: 1US FAERS
153Neck PainFAERS: 1US FAERS
154NecrosisFAERS: 1US FAERS
155NephrolithiasisFAERS: 1US FAERS
156No adverse eventFAERS: 1US FAERS
157Obsessive-Compulsive DisorderFAERS: 1US FAERS
158PallorFAERS: 1OFFSIDES
US FAERS
159Pancreatic carcinomaFAERS: 1US FAERS
160Pancreatic enlargementFAERS: 1US FAERS
161Pancreatic toxicityFAERS: 1US FAERS
162Penis carcinomaFAERS: 1US FAERS
163Peptic UlcerFAERS: 1US FAERS
164Personality ChangeFAERS: 1US FAERS
165PharyngitisFAERS: 1US FAERS
166Pharyngolaryngeal PainFAERS: 1US FAERS
167Pityriasis RoseaFAERS: 1US FAERS
168Pneumocystis jiroveci pneumoniaFAERS: 1US FAERS
169PregnancyFAERS: 1US FAERS
170Product administration errorFAERS: 1US FAERS
171Product depositFAERS: 1US FAERS
172Product formulation issueFAERS: 1US FAERS
173Product solubility abnormalFAERS: 1US FAERS
174Product storage errorFAERS: 1US FAERS
175Product use issueFAERS: 1US FAERS
176Productive CoughFAERS: 1US FAERS
177Pseudomonas test positiveFAERS: 1US FAERS
178Psychomotor skills impairedFAERS: 1US FAERS
179Pulmonary renal syndromeFAERS: 1US FAERS
180Renal abscessFAERS: 1US FAERS
181Renal tubular necrosisFAERS: 1US FAERS
182Serum SicknessFAERS: 1OFFSIDES
US FAERS
183Sinus TachycardiaFAERS: 1US FAERS
184Skin UlcerFAERS: 1US FAERS
185Skin lesionFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
186Skin reactionFAERS: 1US FAERS
187Sperm count decreasedFAERS: 1US FAERS
188Spermatozoa morphology abnormalFAERS: 1US FAERS
189Spermatozoa progressive motility decreasedFAERS: 1US FAERS
190StomatitisFAERS: 1SIDER
US FAERS
191StressFAERS: 1US FAERS
192Therapeutic response unexpectedFAERS: 1US FAERS
193Therapeutic response unexpected with drug substitutionFAERS: 1US FAERS
194Therapy cessationFAERS: 1US FAERS
195ThrombocytosisFAERS: 1US FAERS
196TransplantFAERS: 1US FAERS
197Violence-related symptomFAERS: 1US FAERS
198Weaning failureFAERS: 1US FAERS
199Wrong doseFAERS: 1US FAERS
200furuncleFAERS: 1OFFSIDES
US FAERS
201Abdominal adhesionsOFFSIDES
202Abdominal sepsisOFFSIDES
203Abdominal tendernessOFFSIDES
204AbscessCanada Vigilance: 1Canada Vigilance
OFFSIDES
205AcidosisOFFSIDES
206Acquired pyloric stenosisOFFSIDES
207Acrodermatitis18711101CTD
208Activated partial thromboplastin time abnormalOFFSIDES
209Acute Coronary SyndromeOFFSIDES
210Acute otitis mediaOFFSIDES
211Acute sinusitisOFFSIDES
212AdenitisOFFSIDES
213AdenocarcinomaOFFSIDES
214Adenoviral hepatitisOFFSIDES
215Adverse eventOFFSIDES
216AgraphiaOFFSIDES
217AmphetaminesOFFSIDES
218Anal abscessOFFSIDES
219Anemia4552812
4560141		CTD
220AnhidrosisOFFSIDES
221Anorectal discomfortOFFSIDES
222AnorexiaSIDER
223Anticholinergic SyndromeOFFSIDES
224Antidepressant drug clearance decreasedOFFSIDES
225Antinuclear antibody increasedOFFSIDES
226Antithrombin III decreasedOFFSIDES
227ArthritisOFFSIDES
228Arthropod biteOFFSIDES
229Artificial crown procedureOFFSIDES
230AspergillomaOFFSIDES
231AtaxiaOFFSIDES
232AthetosisOFFSIDES
233Atrial FlutterOFFSIDES
234Atrial thrombosisOFFSIDES
235AzoospermiaOFFSIDES
SIDER
236Bacteria blood identifiedOFFSIDES
237Bacterial sepsisOFFSIDES
238Biopsy lung abnormalOFFSIDES
239Biopsy spleen abnormalCanada Vigilance: 1Canada Vigilance
240Bladder cancer recurrentOFFSIDES
241Blast cell count increasedOFFSIDES
242Blast cells presentOFFSIDES
243BlastomycosisOFFSIDES
244Blood albumin increasedOFFSIDES
245Blood and lymphatic system disordersSIDER
246Blood beta-D-glucan increasedOFFSIDES
247Blood creatine phosphokinase increasedOFFSIDES
248Blood creatinine decreasedOFFSIDES
249Blood fibrinogenOFFSIDES
250Blood glucose decreasedOFFSIDES
251Blood glucose fluctuationOFFSIDES
252Blood glucose increasedCanada Vigilance: 1Canada Vigilance
253Blood growth hormone decreasedOFFSIDES
254Blood immunoglobulin A decreasedOFFSIDES
255Blood immunoglobulin G decreasedOFFSIDES
256Blood magnesium decreasedOFFSIDES
257Blood phosphorus increasedOFFSIDES
258Blood thyroid stimulating hormoneOFFSIDES
259Blurred visionOFFSIDES
260Bone marrow depressionOFFSIDES
SIDER
261Bone marrow toxicitySIDER
262Brain DeathOFFSIDES
263Breast CystOFFSIDES
264Breast cancer stage IIIOFFSIDES
265BronchiolitisOFFSIDES
266BronchitisCanada Vigilance: 1Canada Vigilance
267Bronchoalveolar LavageOFFSIDES
268Bronchoalveolar lavage abnormalOFFSIDES
269Bulbar palsyOFFSIDES
270Candida endophthalmitisOFFSIDES
271Candida pneumoniaOFFSIDES
272Candida sepsisOFFSIDES
273CarcinomaOFFSIDES
274CarotidyniaOFFSIDES
275Cavernous Sinus ThrombosisOFFSIDES
276Central nervous system lesionOFFSIDES
277Cerebral disorderOFFSIDES
278CerebrosclerosisOFFSIDES
279CheilitisOFFSIDES
280Chemical and Drug Induced Liver Injury22166485
28437613		CTD
281Chest wall painOFFSIDES
282CholangiolitisOFFSIDES
283Chorioretinal atrophyOFFSIDES
284Chronic sinusitisOFFSIDES
285Chronic ulcerative colitisOFFSIDES
286Coagulation factor VIII level increasedOFFSIDES
287CoccidioidomycosisOFFSIDES
288Complex partial seizuresOFFSIDES
289Contraindicated product administeredCanada Vigilance: 2Canada Vigilance
290Cord blood transplant therapyOFFSIDES
291Creatinine renal clearance decreasedCanada Vigilance: 1Canada Vigilance
292Crohn Disease

View details

14505127
18711101
19652986
25108385
 		CTD
293Culture wound positiveOFFSIDES
294Cutaneous CandidiasisOFFSIDES
295CystSIDER
296Cytomegalovirus antibody positiveOFFSIDES
297Cytomegalovirus hepatitisOFFSIDES
298CytopeniaSIDER
299Decreased ventricular afterloadOFFSIDES
300Delayed PubertyOFFSIDES
301DemyelinationOFFSIDES
302Depressed Level of ConsciousnessOFFSIDES
303DermatitisSIDER
304Device related infectionOFFSIDES
305DiarrheaOFFSIDES
306Diffuse alveolar damageOFFSIDES
307Disseminated Intravascular CoagulationOFFSIDES
308Drug DependenceCanada Vigilance: 1Canada Vigilance
309Drug Eruptions17576940
18711101		CTD
310Drug delivery system malfunctionOFFSIDES
311Drug exposure during pregnancyOFFSIDES
312Drug withdrawal headacheOFFSIDES
313Ear discomfortOFFSIDES
314Embolic strokeOFFSIDES
315EncephalitisOFFSIDES
316Enterobacter sepsisOFFSIDES
317Enterocutaneous FistulaOFFSIDES
318Epidural AbscessOFFSIDES
319EpilepsyOFFSIDES
320EpiscleritisOFFSIDES
321Epstein-Barr virus antigen positiveOFFSIDES
322Epstein-Barr virus associated lymphoproliferative disorderOFFSIDES
323Escherichia infectionOFFSIDES
324Esophageal StenosisOFFSIDES
325Exfoliative rashOFFSIDES
326Eye painOFFSIDES
327Familial Mediterranean FeverOFFSIDES
328Fatty LiverOFFSIDES
329Fetal Growth Retardation22688000CTD
330Flat affectOFFSIDES
331FormicationOFFSIDES
332Gallbladder necrosisOFFSIDES
333Gamma-Glutamyltransferase IncreasedCanada Vigilance: 1Canada Vigilance
334Gastroenteritis norovirusOFFSIDES
335Gastrointestinal Diseases4552812CTD
336Gastrointestinal erosionOFFSIDES
337Gastrointestinal inflammationCanada Vigilance: 1Canada Vigilance
OFFSIDES
338Gastrointestinal perforationOFFSIDES
339GastroschisisOFFSIDES
340Gene MutationOFFSIDES
341GlaucomaOFFSIDES
342Glioblastoma MultiformeOFFSIDES
343GliomaOFFSIDES
344GliosisOFFSIDES
345Graft infectionOFFSIDES
346Gram stain positiveOFFSIDES
347Guillain-Barre SyndromeCanada Vigilance: 1Canada Vigilance
348Heart Diseases2727390
22166485		CTD
349Hematuria5038956CTD
350HemiparesisOFFSIDES
351Hepatic candidiasisOFFSIDES
352Hepatic congestionOFFSIDES
353Hepatitis, Chronic7433331CTD
354HepatosplenomegalyOFFSIDES
355HerniaCanada Vigilance: 1Canada Vigilance
356HistoplasmosisOFFSIDES
357Humoral immune defectOFFSIDES
358Hungry bone syndromeOFFSIDES
359HydrocephalusOFFSIDES
360Hyperplasia21272804CTD
361Hyperplastic cholecystopathyOFFSIDES
362HypokinesiaCanada Vigilance: 1Canada Vigilance
363HypometabolismOFFSIDES
364HysterectomyOFFSIDES
365Ileal StenosisOFFSIDES
366ImmobileOFFSIDES
367Impaired driving abilityOFFSIDES
368Impaired quality of lifeCanada Vigilance: 1Canada Vigilance
369Incisional herniaOFFSIDES
370Infantile apnoeic attackOFFSIDES
371Infection in an immunocompromised hostOFFSIDES
372Infective spondylitisOFFSIDES
373Inflammatory Bowel Diseases8050312
18662289		CTD
374Infusion site mobility decreasedOFFSIDES
375Inguinal massOFFSIDES
376Injection site erythemaOFFSIDES
377Injection site inflammationOFFSIDES
378Injection site irritationOFFSIDES
379Injection site massOFFSIDES
380Injection site pruritusOFFSIDES
381Injection site urticariaOFFSIDES
382Injection site warmthOFFSIDES
383Intestinal FistulaOFFSIDES
384Intracranial HypotensionOFFSIDES
385Intraspinal abscessOFFSIDES
386Iron OverloadOFFSIDES
387Joint warmthOFFSIDES
388Lactobacillus infectionOFFSIDES
389LegionellaOFFSIDES
390LethargyOFFSIDES
391Leukemia, Myelomonocytic, Chronic10644815CTD
392LeukoaraiosisOFFSIDES
393LeukoencephalopathyOFFSIDES
394Leukopenia neonatalOFFSIDES
395Limb Deformities, Congenital22688000CTD
396Limb injuryOFFSIDES
397Listeria sepsisOFFSIDES
398ListeriosisOFFSIDES
399Liver AbscessOFFSIDES
400Liver Cirrhosis169114CTD
401Liver diseases67817
1058041
21272804		CTD
402Loss of proprioceptionOFFSIDES
403Lower respiratory tract infection fungalOFFSIDES
404Lupus-like syndromeOFFSIDES
405LymphocytosisOFFSIDES
406Lysosomal Storage Diseases28551711CTD
407MalabsorptionSIDER
408Malignant GliomaOFFSIDES
409Malignant melanoma in situOFFSIDES
410MalnutritionSIDER
411MastoiditisOFFSIDES
412Mechanical ventilationOFFSIDES
413Mental impairmentOFFSIDES
414MetaplasiaOFFSIDES
415Metapneumovirus infectionOFFSIDES
416Molluscum ContagiosumOFFSIDES
417MonocytosisOFFSIDES
418MononeuritisOFFSIDES
419MucormycosisOFFSIDES
420MumpsOFFSIDES
421Muscle WeaknessOFFSIDES
422Muscle necrosisOFFSIDES
423Musculoskeletal discomfortSIDER
424MutismOFFSIDES
425MyelodysplasiaOFFSIDES
426MyelosuppressionSIDER
427Myocardial fibrosisOFFSIDES
428Neutrophil count abnormalOFFSIDES
429NocturiaOFFSIDES
430Non-small cell lung cancer recurrentOFFSIDES
431NystagmusOFFSIDES
432ObstructionOFFSIDES
433OligospermiaSIDER
434OliguriaOFFSIDES
435OphthalmoplegiaOFFSIDES
436Optic NeuritisOFFSIDES
437Optic NeuropathyOFFSIDES
438Oral candidiasisSIDER
439Oral lesionSIDER
440Oropharyngeal blisteringOFFSIDES
441Oropharyngeal discomfortOFFSIDES
442Oropharyngeal painOFFSIDES
443OsteomyelitisOFFSIDES
444OverweightOFFSIDES
445Pancreatic PseudocystOFFSIDES
446ParaparesisOFFSIDES
447ParaplegiaOFFSIDES
448Paresis7198574CTD
449Paroxysmal arrhythmiaOFFSIDES
450Pelvic abscessOFFSIDES
451Peptic Ulcer PerforationCanada Vigilance: 1Canada Vigilance
452Perianal abscessOFFSIDES
453Peripancreatic fluid collectionOFFSIDES
454PeritonitisCanada Vigilance: 1Canada Vigilance
455PhlebitisOFFSIDES
456Plasminogen decreasedOFFSIDES
457Platelet count abnormalOFFSIDES
458Platelet function test abnormalOFFSIDES
459PneumoperitoneumOFFSIDES
460PneumothoraxOFFSIDES
461PolyneuropathyOFFSIDES
462PolyuriaOFFSIDES
463Post lumbar puncture syndromeOFFSIDES
464Postoperative abscessOFFSIDES
465Postural Orthostatic Tachycardia SyndromeOFFSIDES
466PosturingOFFSIDES
467Pre-EclampsiaOFFSIDES
468Precancerous skin lesionCanada Vigilance: 1Canada Vigilance
469Precocious PubertyOFFSIDES
470Precursor B-Cell Lymphoblastic Leukemia-Lymphoma18176182
21064136		CTD
471Precursor T-Cell Lymphoblastic Leukemia-Lymphoma20167372CTD
472Primary hypogonadismOFFSIDES
473Product residue presentCanada Vigilance: 1Canada Vigilance
474Protein C decreasedOFFSIDES
475Protein S decreasedOFFSIDES
476Prothrombin time ratio decreasedOFFSIDES
477Pseudobulbar PalsyOFFSIDES
478Pulmonary necrosisOFFSIDES
479Pulmonary toxicityOFFSIDES
480PurulenceOFFSIDES
481Pustular psoriasisOFFSIDES
482Pyloric StenosisOFFSIDES
483Pyoderma GangrenosumOFFSIDES
484Rectal StenosisOFFSIDES
485Refusal of treatment by relativeOFFSIDES
486Renal Insufficiency22166485CTD
487Renal embolismOFFSIDES
488Respiratory FailureOFFSIDES
489Respiratory syncytial virus test positiveOFFSIDES
490Respiratory tract congestionOFFSIDES
491Retinoic acid syndromeOFFSIDES
492Retroperitoneal fibrosisOFFSIDES
493RhinitisOFFSIDES
494RhinorrheaOFFSIDES
495Scan abdomen abnormalOFFSIDES
496SchizophreniaOFFSIDES
497Seizures15794179CTD
498Sinus Thrombosis, Intracranial4056835CTD
499Sinus headacheOFFSIDES
500Sinus polypOFFSIDES
501SinusitisOFFSIDES
502Skin IndurationOFFSIDES
503Skin graft failureOFFSIDES
504Skin tightnessOFFSIDES
505Small intestine carcinomaOFFSIDES
506Splenic InfarctionOFFSIDES
507Splenic abscessOFFSIDES
508SpondylolisthesisOFFSIDES
509SprueSIDER
510StenosisCanada Vigilance: 2Canada Vigilance
511Subcutaneous noduleOFFSIDES
512Tarsal Tunnel SyndromeOFFSIDES
513TenosynovitisOFFSIDES
514Therapy non-responderOFFSIDES
515Thymus enlargementOFFSIDES
516Tongue bitingOFFSIDES
517TonsillitisOFFSIDES
518Treatment related secondary malignancyOFFSIDES
519Unresponsive to verbal stimuliOFFSIDES
520Urine ketone body presentOFFSIDES
521Vaginal FistulaOFFSIDES
522Ventricular FibrillationOFFSIDES
523Viral pharyngitisOFFSIDES
524Visual brightnessOFFSIDES
525Visual disturbanceOFFSIDES
526White blood cell count abnormalOFFSIDES
527Wound abscessOFFSIDES
528Wrong drug administeredOFFSIDES
529X-linked chromosomal disorderOFFSIDES
530XerosisOFFSIDES
531leukemia581272
22688000
23358152		CTD
532muscle injuryOFFSIDES
533prostatitisOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.